期刊文献+

血清胃蛋白酶原和胃泌素-17在胃癌筛选中的作用 被引量:14

下载PDF
导出
摘要 胃癌是全球最常见的恶性肿瘤之一,提高胃癌的早期诊断率是降低胃癌的发生率和死亡率的重要手段。近年来血清学检测因简便、便于动态监测而在国外被广泛应用。此文主要介绍血清胃蛋白酶原和胃泌素-17的临床意义及单独或联合检测在胃癌及其癌前病变筛选中的作用,指导进一步研究以寻找适合国内胃癌筛选的最佳方法。
出处 《国际消化病杂志》 CAS 2012年第2期85-87,共3页 International Journal of Digestive Diseases
基金 江苏省自然基金资助项目(BK2010024)
  • 相关文献

参考文献21

  • 1Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis, 2007, 8: 8-14.
  • 2Correa P. Human gastric carcinogenesis: a multi step and multifactorial process, First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 1992, 52: 6735-6740.
  • 3Hattori Y, Tashiro H, Kawamoto T, et al. Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens. Jpn J Cancer Res, 1995, 86: 1210-1215.
  • 4Mukoubayashi C, Yanaoka K, Ohata H, et al. Serum pepsinogen and gastric cancer screening. Intern Med, 2007, 46: 261-266.
  • 5Derakhshan MH, El-Omar E, Oien K, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with helicohacter pylori. J Clin Pathol, 2006, 59:1293-1299.
  • 6Oishi Y, Kiyohara Y, Kubo M, et al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol, 2006, 163 : 629-637.
  • 7Di Mario F, Cavallaro LG, Moussa AM, et al. Usefulness of serum pepsinogens in helicobacter pylori chronic gastritis: relationship with in ammation, activity, and density of the bacterium. Dig Dis Sci, 2006, 51 : 1791-1795.
  • 8Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal meta-plasia in patients in whom helicobacter pylori was eradicated. Ann Intern Med, 2001,134: 380-386.
  • 9Ferrand A, Wang TC. Gastrin and cancer: a review. Cancer Lett, 2006, 238:15- 29.
  • 10Asaka M, Kimura T, Kudo M, et al. Relationship of helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology, 1992, 102 :760- 766.

二级参考文献35

  • 1李哲夫,王德昭,乐竹琴.胃泌素与胃癌[J].国外医学(消化系疾病分册),1993,13(2):69-72. 被引量:11
  • 2Victor D.Pasechnikov,Sergey Z.Chukov,Sergey M. Kotelevets,Alexander N. Mostovov,Varvara P. Mernova,Maria B. Polyakova.Possibility of non-invasive diagnosis of gastric mucosal precancerous changes[J].World Journal of Gastroenterology,2004,10(21):3146-3150. 被引量:7
  • 3中国慢性胃炎共识意见[J].胃肠病学,2006,11(11):674-684. 被引量:833
  • 4Antonio Rollan,Catterina Ferreccio,Alessandra Gederlini,Carolina Serrano,Javiera Torres,Paul Harris.Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer[J].World Journal of Gastroenterology,2006,12(44):7172-7178. 被引量:14
  • 5Ferlay J,Bray F,Pisani P,Parkin DM.GLOBOCAN 2000:Cancer Incidence,Mortality and Prevalence Worldwide.Version 1.0.IARC Cancer Base No.5.Lyon:IARC Press,2001.
  • 6Sipponen P,Kekki M,Haapakoski J,Ihamaki T,Siurala M.Gastric cancer risk in chronic atrophic gastritis:statistical calculations of cross-sectional data.Int J Cancer,1985,35:173~177.
  • 7Koga M,Miyakawa K,Ikeda S.Annual Report of Gastroenterological Mass Survey in Japan,2002.Tokyo:Japanese Society of Gastroenterology Mass Survey.2004.
  • 8Sipponen P,Ranta P,Helske T,Kaariainen I,Maki T,Linnala A,Suovaniemi O,Alanko A,Harkonen M.Serum levels of amidated gastrin-17 and pepsinogen Ⅰ in atrophic gastritis:an observational case-control study.Scand J Gastroenterol,2002,37:785~791.
  • 9Sipponen P,Harkonen M,Alanko A,Suovaniemi O.Diagnosis of atrophic gastritis from a serum sample.Clin Lab,2002,48:505~515.
  • 10Vaananen H,Vauhkonen M,Helske T,Kaariainen Ⅰ,Rasmussen M,Tunturi-Hihnala H,Koskenpato J,Sotka M,Turunen M,Sandstrom R,Ristikankare M,Jussila A,Sipponen P.Non-endoscopic diagnosis of atrophic gastritis with a blood test.Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen Ⅰ:a multicentre study.Eur J Gastroenterol Hepatol,2003,15:885~891.

共引文献123

同被引文献91

引证文献14

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部